Using sequence analysis to detect variation within the hypervariable M protein N terminus, we found 41 emm types encompassing 81 subtypes, among 1064 consecutive invasive group A streptococcus isolates from a recent multistate, population-based surveillance. Seventeen of the 30 emm types represented by multiple isolates displayed multiple subtypes. Most subtypes differed from reference strain emm sequences as a result of single base substitutions or other alterations likely to be stably inherited. The Centers for Disease Control and Prevention database (available at: http://www .cdc.gov/ncidod/biotech/strep/strepblast.htm) currently contains 225 distinct emm types encompassing 450 subtypes. Although this subtyping scheme increases specificity, limited variation within individual types favors introduction of M protein type-specific vaccines.
the most relevant for vaccine development. Such a scheme also increases the specificity of M typing, on which epidemiologic typing of GAS has been based for decades.
For the past 8 years, the Centers for Disease Control and Prevention (CDC) has been performing population-based active surveillance for invasive GAS [6] and M protein gene (emm) typing of isolates (emm sequences sharing 195% identity over a sequence of 160 5 bases with the CDC M type reference strain are assigned the reference emm type [7] ). Although typing of CDC GAS strain is based on this system, we often use judicious emm sequence typing of representative isolates, together with emm amplicon restriction profiling (with at least 2 independent restriction digests using different enzyme combinations) and T antigen typing, to deduce emm types (see http: //www.cdc.gov/ncidod/biotech/strep/protocols.htm). We have found this strategy to be highly accurate for determining emm types; however, only emm amplicon sequence analysis of all isolates will allow determination of the extent of allelic variation within the N-terminal type-specific regions that elicit typespecific protective antibodies. Therefore, to perform this determination, we sequenced the M type-specific regions from 1061 consecutive invasive GAS isolates.
Materials and methods. Invasive GAS isolates were recovered during 2000 and early 2001, from areas within 9 states, as described at http://www.cdc.gov/ncidod/dbmd/abcs/. The 9 states included Minnesota (181 isolates), Maryland (171 isolates), California (168 isolates), Connecticut (157 isolates), Colorado (137 isolates), Georgia (131 isolates), New York (60 isolates), Oregon (30 isolates), and Tennessee (29 isolates). Each isolate represented an independent case of invasive disease. Isolates were considered to be invasive if they were recovered from blood, cerebrospinal fluid, pleural fluid, peritoneal fluid, pericardial fluid, surgical aspirate, bone, joint fluid, or from tissue during surgery (e.g., muscle collected during debridement for necrotizing fasciitis).
Isolates were identified as GAS by use of slide agglutination (Phadebact Streptococcus Tests; Boule Diagnostics AB) and were sequence typed, as described at http://www.cdc.gov/ncidod /biotech/strep/protocols.htm. Sequences that shared 195% identity within bases 1-160, that were obtained with primer emmseq2 and that contained no more than 1 alteration of the reading frame within this sequence affecting р7 codons were assigned the same emm type. emm Types are designated with either the prefix emm (accepted as an M protein gene by an international panel [8] ) or st (recently discovered sequence types with limited known global distributions). Subtypes were assigned on the basis of any alterations within the coding region for the predicted 50 N-terminal residues of the processed M protein. Signal cleavage sites were deduced as described elsewhere [9] (see also: http://www.cbs.dtu.dk/services/SignalP/). New sequence types and subtypes were screened against the GenBank database, to determine whether they had been described previously.
Results. The 450 subtypes distributed among 225 previously defined emm types [7, 8, [10] [11] [12] [7.7%] ). Also consistent with these results [6] was the finding that 17 types represented 83% of the isolates. Subtype emm1.0 was the most common type in 6 of the 9 surveillance areas, representing 14%-22% of the isolates in these areas, and was the second-most-common type in the other 3 areas (12%-17% of isolates). Types representing у25 isolates were distributed among у6 states, with the exception of type emm82. Fifty-four of the 63 emm82.0 isolates (85.7%) were recovered in Maryland (data not shown). Sixteen types consisted of single isolates, and 5 types consisted of 2 isolates each.
Subtypes designated with ".0" depict CDC reference strain sequences ( compared with emm1 subtypes; we have not altered its designation here, in deference to the original discoverers [12] ).
Notable examples in which the majority of isolates within a type did not share identity with CDC M type reference strains were observed. Eighty-two (75.9%) of 108 type emm3 isolates were subtype emm3.1, which differed by 2 residues from the CDC reference strain. These 2 residues were shared by all 7 emm3 subtypes encountered, including emm3. 4 , which was found among 19.4% of type emm3 isolates. The reference subtype (emm3.0) was not observed among the 108 type emm3 isolates. The most common subtype within type emm5 was emm5.14, which differed from emm5.0 within codon 1. This same codon-1 substitution was found among the other 4 emm5 subtypes encountered. Type emm6 was represented by the reference subtype emm6.0 and 4 other subtypes, all differing within C terminal residues 35-50 of the type-specific region. Many subtypes of M5 and of M6 arise, apparently because of different patterns of homologous repeat-sequence excisions that flank and overlap the N-terminal 50 type-specific codons, and, because of this, may not represent stable epidemiologic markers [13] . Although other types, such as emm1 and emm3, also show an extensive array of subtypes (table 1), in contrast to emm5 and emm6, each has a common major subtype, presumably because of a lack of unstable, extensive repeat regions adjacent to their N-terminus encoding sequences. Other types for which the reference strain subtype either was not represented among survey isolates or was seen within a minority of isolates included emm41, emm83, emm102, emm31, emm68, emm9, emm29, emm63, emm48, emm14, and emm60 (table 1) .
Five new types (6 isolates) were found, only 1 of which shared a high relatedness to a previously characterized GAS emm type. Type st3850 (single isolate) shared 90% sequence identity with the N-terminal 50 residues of the rarely seen Lancefield type emm56.0. Subtypes st6030.0 and st6030.1 were found in single isolates recovered in Connecticut and San Francisco, respectively. Subtype st6030.0, which shares 50% deduced amino acid sequence identity with M100.0, also has been observed from a skin-lesion isolate obtained from a Nepalese child (authors' unpublished data). Type st369 (st369.0), which has weak similarity to M76.1 (40% identity), recently was found in a throat isolate from a child with pharyngitis in Mexico City [14] . Interestingly, stL2764.0 (∼40% deduced identity with M71.0) was originally observed in the group L S. dysgalactiae subspecies equisimilis CDC reference strain (authors' unpublished data). Types st3850 and st5282 (59% identity with M15.0) have only been observed within the single isolates described in this study.
Discussion. The CDC emm sequence database was constructed through the analysis of Lancefield reference strains, clinical isolates recovered from the United States, and isolates recovered from several other countries [6, 7, 11, 14] . If multivalent vaccines based on M protein type-specific sequences 
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Downloaded from https://academic.oup.com/jid/article-abstract/188/10/1587/921746 by guest on 03 January 2019 The purpose of the present study was to depict subtype distribution among invasive isolates recently recovered within the United States. Because these data represent surveillance during only portions of 2 calendar years and from only sections of the respective surveillance areas, the present report is not a population-based analysis of invasive GAS disease during these years. This said, the type distribution presented in table 1 is in general agreement with the type distribution of invasive GAS in the United States during 1995-1999, as obtained from Active Bacterial Core Surveillance [6] . In the previous report [6] , a population-based survey of 12000 GAS isolates, it was found that types emm1, emm28, emm12, emm3, and emm11 accounted for 49.2% of the isolates. In the present study, these types accounted for 48.0% of the 1064 isolates. It is notable that the 5 types found in the previous study and 18 additional types found in the present study accounted for 82.9% of the study isolates and are included in a 26-valent M type-specific vaccine that is currently undergoing clinical trials [1] (see also http:// www.idbiomed.com/vaccines_frameset.html). In the previous report [6] , newly characterized emm types accounted for 8.9% of invasive isolates. Among the 1064 invasive isolates described here, new types accounted for !0.6% of invasive isolates. This observation indicates that we have encountered the majority of types that circulate within the United States. Our surveillance in several different countries offers evidence suggesting that we have encountered most of the emm types that circulate worldwide. For example, in a recent study of type distribution among noninvasive isolates from children in rural Nepalese villages, we encountered 46 distinct emm types, only 2 of which we had not encountered elsewhere (authors' unpublished data).
The availability of subtype information will allow analysis of the degree of protection afforded across subtypes by M typespecific vaccines. Although alterations between subtypes are generally slight, common subtypes-such as emm3.4, emm89.1, and emm11.1-as well as various emm5 and emm6 subtypes, are being analyzed in this regard (J. Dale, personal communication).
Subtype information also increases the specificity of epidemiologic information. This approach has already been informative in determining epidemiologic links between isolates. In one circumstance involving serious GAS disease, we confirmed an epidemiologic link among 4 isolates from clinical and environmental sites that shared the rare subtype emm3.14 (differs by a single base in the type-specific region relative to the common subtype emm3.1).
In summary, we have created a database available on the Internet for emm subtype determination and have demonstrated its usefulness in subtyping 1064 invasive isolates. This database should help facilitate GAS epidemiologic investigations and specialized laboratory studies. The corresponding strains are available to assist researchers performing various studies, including those related to M protein-based vaccines, M protein function and virulence, and GAS population genetics. The data compiled from these 1064 isolates demonstrate a remarkable degree of conservation within the regions containing protective epitopes of common M types, where the majority of sequences apparently have not appreciably changed for at least 30-60 years. This information suggests that there are structural constraints within M proteins that are required for essential function(s). It follows that such constraints on antigenic change could possibly be exploited in type-specific vaccines formulated against this pathogen.
